WuXi AppTec(SH:603259) Jin Rong Jie·2025-04-11 10:05Core Viewpoint - The China Securities Hong Kong Biotechnology Theme Index has shown a mixed performance, with a recent decline but a notable increase over the past three months and year-to-date [1][2] Group 1: Index Performance - The China Securities Hong Kong Biotechnology Theme Index reported a value of 1155.57 points, with a decline of 4.92% over the past month, an increase of 20.52% over the past three months, and a year-to-date increase of 13.66% [1] - The index is composed of 50 listed companies in the fields of biopharmaceuticals, pharmaceuticals, and biotechnology services, reflecting the overall performance of biotechnology theme stocks listed in Hong Kong [1] Group 2: Index Composition - The top ten weighted companies in the index are: BeiGene (15.21%), WuXi Biologics (11.43%), Innovent Biologics (10.19%), CanSino Biologics (7.71%), CSPC Pharmaceutical Group (6.08%), China Biologic Products (5.62%), Hansoh Pharmaceutical (3.77%), Zai Lab (3.43%), 3SBio (3.27%), and WuXi AppTec (2.83%) [1] - The index is fully composed of stocks listed on the Hong Kong Stock Exchange, with a 100% allocation [1] Group 3: Industry Breakdown - The industry composition of the index shows that biopharmaceuticals account for 52.79%, chemical drugs for 24.55%, pharmaceutical and biotechnology services for 18.85%, and medical devices for 3.81% [2] - The index samples are adjusted semi-annually, with adjustments occurring on the next trading day after the second Friday of June and December each year [2]